Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool

CompletedOBSERVATIONAL
Enrollment

942

Participants

Timeline

Start Date

April 17, 2017

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Diabetic RetinopathyDiabetic Eye ProblemsDiabetic Macular Edema
Interventions
PROCEDURE

Color fundus photography

Subjects will undergo fundus photography before and after administration of mydriatic agent.

DRUG

Mydriatic Agent

Subjects will be administered mydriatic medication to dilate their pupils.

Trial Locations (1)

90502

Los Angeles Biomedical Research Institute, Los Angeles

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

lead

Eyenuk, Inc.

INDUSTRY

NCT03112005 - Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool | Biotech Hunter | Biotech Hunter